1. Cisplatin Resistance and Redox-Metabolic Vulnerability: A Second Alteration
   Medhi Wangpaichitr et al, 2021, International Journal of Molecular Sciences CrossRef
2. Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-d-glucose under hypoxia in lung cancer cell lines
   Medhi Wangpaichitr et al, 2008, Molecular Cancer Therapeutics CrossRef
3. Activation of ABCC Genes by Cisplatin Depends on the CoREST Occurrence at Their Promoters in A549 and MDA-MB-231 Cell Lines
   Maciej Sobczak et al, 2022, Cancers CrossRef